| In partnership with |  |
| & Altucher's Investment Network | Happy Monday, 360 - | Here are some of our top movers today! | ⏰ And set a reminder to join Jeff Bishop LIVE @ 11am EST today as he reviews his top trading ideas for the week in the Market Master's trading room. All are welcome! | | | FOCUS LIST🔎 | WBUY - Up over 120% in the pre-market after announcing it had advanced to the next phase of NVIDIA's AI accelerator program | RCAT - Up over 20% in pre after announcing partnership with Palantir to equip Black Widow™ with autonomous visual navigation and warp speed for gps-compromised environments | CKPT - Up over 15% in pre after announcing FDA approval of UNLOXCYT™ (cosibelimab-ipdl) | | *sponsored by Perpetua Life | Novaxidil Triple Action Hair Regrowth Treatment | | Stop Hair Loss, AND Stimulate ReGrowth Only Clinically Proven Ingredients Minoxidil, K-Conazole, Nicotinamide, Vitamin-K, Biotin, and Collagen Peptides.
| Learn more |
|
| | HOTLIST🔥 | WBUY - Up over 120% in the pre-market after announcing it had advanced to the next phase of NVIDIA's AI accelerator program | Webuy Global Ltd (WBUY) operates as an e-commerce retailer company in Singapore, Indonesia, and Malaysia. | In the pre-market this morning, the company announced its advancement to the next phase of NVIDIA's AI Accelerator Program. This milestone reflects Webuy's commitment to leveraging advanced AI technologies to enhance its offerings and deliver exceptional value to its customers. | The NVIDIA AI Accelerator Program, supported by Singapore's Economic Development Board (EDB), Tribe (a leading blockchain accelerator in Asia), and the Digital Industry Singapore (DISG, a joint office of EDB, Enterprise Singapore, and IMDA) provides startups and businesses with access to NVIDIA's state-of-the-art computing resources and technical expertise. | Shares of WBUY traded up over 120% in the pre-market in reaction to the news. | | The first target for bulls is the pre-market high at $0.4050. Beyond that, $0.50, $0.5773 and $0.75 come into play. | Below $0.4050, targets to the downside are $0.35, $0.32, $0.2850, $0.2550, $0.2420, $0.20 and then a gap fill at $0.1756. | | RCAT - Up over 20% in pre after announcing partnership with Palantir to equip Black Widow™ with autonomous visual navigation and warp speed for gps-compromised environments | Red Cat Holdings Inc. (RCAT) together with its subsidiaries, provides various products, services, and solutions to the drone industry in the United States. | In the pre-market this morning, the company announced a strategic partnership with Palantir Technologies Inc. (PLTR) to integrate Visual Navigation software (VNav) into Red Cat's Black Widow drones and to deploy Warp Speed, Palantir's manufacturing OS. | This collaboration will transform autonomous sUAS operations for modern warfare by utilizing Palantir's advanced AI software running onboard the drone which references up-to-date onboard satellite imagery to provide accurate navigation entirely independent of GPS or radio control signals. | Shares of RCAT traded up over 20% in the pre-market in reaction to the news. | | The $8.95 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $9.30, $9.55, $9.70 and then the pre-market high at $10.40. | Below $8.95, targets to the downside are $8.65 and then $8.48 with a gap fill at $8.23. | | *sponsored by Altucher's Investment Network | Missed out on crypto? Here's the good news. | If you feel like you missed out on Bitcoin or crypto, there's good news on the horizon. James Altucher, a genius investor who famously called the success of Bitcoin in 2011, says AI is the next big thing—and it's going to be 10X bigger than crypto. According to Altucher, a once-in-a-lifetime "wealth window" in AI is opening, but it will close soon | See what he's predicting here |
|
| | CKPT - Up over 15% in pre after announcing FDA approval of UNLOXCYT™ (cosibelimab-ipdl) | Checkpoint Therapeutics Inc. (CKPT) is a clinical-stage immunotherapy and targeted oncology company that focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers in the United States and internationally. | In the after-hours Friday, the company announced that the U.S. Food and Drug Administration (FDA) has approved UNLOXCYT™ (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma ("cSCC") or locally advanced cSCC who are not candidates for curative surgery or curative radiation. | UNLOXCYT is the first and only programmed death ligand-1 ("PD-L1") blocking antibody to receive FDA marketing approval for this indication. | Shares of CKPT traded up over 10% in the pre-market in reaction to the news. | | The $3.95 area acted as support in the pre-market and will be an important level to watch. | Above it, targets to the upside are $4.20, $4.50 and then the pre-market high at $4.78. Beyond that $5, $5.50 and $6 come into play. | Below $3.95, targets to the downside are $3.75 and then a gap fill at $3.67. | | MARKET NEWS 📰 | | P.S. Make sure you text "RAGE" to (888) 404-5747 to get all of our latest HOT STOCK ideas! | | DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at https://ragingbull.com/disclaimer | FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. | RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. | RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers. | RagingBull.com, LLC shall be entitled to recover attorneys' fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys' fees, costs and disbursements in addition to any other relief to which it may be entitled. | *Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don't spend any money on these products or services unless you believe they will help you achieve your goals. | WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication. |
|
|
|
Tidak ada komentar:
Posting Komentar